glp 1 agonists with cardiovascular benefit GLP-1 receptor agonists: The benefits beyond glucose control Comprehensive Overview of GLP-1 RAs
Description
References 1.Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al

Clinical and genetic predictors of glycemic control and weight loss response to liraglutide in patients with type 2 diabetes

2023 Nov 28;13(1):20998
In most employment contexts in the United States, you are not required to disclose prescription medications to your employer unless those medications directly affect your ability to perform essential job functions

Related studies have found that GLP-1RAs could limit the growth of prostate cancer by inhibiting the PI3K/AKT/mTOR and ERK/MAPK pathways, while could also limit the growth of pancreatic and prostate cancer cells by inhibiting the NF-kB pathway (210212)